BCAX vs WELL · $1.51B cap vs P/E 100, rev $10.84B
Bicara Therapeutics Inc. Common Stock (BCAX) versus Welltower Inc (WELL) — a side-by-side from cached financials, not a winner call.
Bicara Therapeutics Inc. Common Stock (BCAX) is a biotechnology company listed on NASDAQ.
Welltower Inc (WELL) is a reit - healthcare facilities company listed on NYSE.
BCAX does not have a complete income-statement cache yet.
Latest reported WELL revenue for 2025-12-31 was $10.84B. Net income was $936.8M. Revenue was up 35.6% from 2024-12-31 to 2025-12-31. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
BCAX currently screens at market cap $1.51B. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
Not investment advice. Open the BCAX and WELL stock pages for the full models.
Not investment advice.